Table 6. Top 10 cancer incidence in China, 2011.
Rank | Both sexes |
Male |
Female |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Site | Cases | Incidence (1/105) | % | ASR* (1/105) | Site | Cases | Incidence (1/105) | % | ASR* (1/105) | Site | Cases | Incidence (1/105) | % | ASR* (1/105) | |||
1 | Lung | 651,053 | 48.32 | 19.31 | 34.87 | Lung | 441,364 | 63.9 | 23.01 | 48.44 | Breast | 248,620 | 37.86 | 17.1 | 28.51 | ||
2 | Breast | 248,620 | 37.86 | 7.49 | 28.51 | Stomach | 296,419 | 42.92 | 15.45 | 32.62 | Lung | 209,689 | 31.93 | 14.43 | 21.93 | ||
3 | Stomach | 420,489 | 31.21 | 12.47 | 22.75 | Liver | 264,635 | 38.32 | 13.79 | 29.3 | Colon & rectum | 131,840 | 20.08 | 9.07 | 14.02 | ||
4 | Liver | 355,595 | 26.39 | 10.54 | 19.48 | Esophagus | 205,560 | 29.76 | 10.71 | 22.47 | Stomach | 124,070 | 18.89 | 8.54 | 13.21 | ||
5 | Colon & rectum | 310,244 | 23.03 | 9.2 | 16.79 | Colon & rectum | 178,404 | 25.83 | 9.3 | 19.7 | Liver | 90,960 | 13.85 | 6.26 | 9.64 | ||
6 | Esophagus | 291,238 | 21.62 | 8.64 | 15.58 | Bladder | 53,074 | 7.68 | 2.77 | 5.82 | Cervix | 87,982 | 13.4 | 6.05 | 10.4 | ||
7 | Cervix | 87,982 | 13.4 | 2.61 | 10.4 | Prostate | 49,007 | 7.1 | 2.55 | 5.33 | Esophagus | 85,678 | 13.05 | 5.89 | 8.85 | ||
8 | Uterus | 57,709 | 8.79 | 1.71 | 6.46 | Pancreas | 45,385 | 6.57 | 2.37 | 4.99 | Thyroid | 67,788 | 10.32 | 4.66 | 8.7 | ||
9 | Prostate | 49,007 | 7.1 | 1.45 | 5.33 | Brain, CNS | 43,289 | 6.27 | 2.26 | 5.22 | Uterus | 57,709 | 8.79 | 3.97 | 6.46 | ||
10 | Ovary | 45,233 | 6.89 | 1.34 | 5.35 | Lymphoma | 41,298 | 5.98 | 2.15 | 4.8 | Ovary | 45,233 | 6.89 | 3.11 | 5.35 |
*, age-standardized incidence rate (China population 2000); CNS, central nervous system.